Atragen Type of group
Sponsors
INSTITUTO DE ENFERMEDADES NEOPLASICAS,
Unknown Phase
A PHASE II MULTICENTRIC STUDY DESIGNED TO EVALUATE ATRAGEN (LIPOSOMAL TRETINOIN ) COMPASSIVE USE IN THE TREATMENT OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Active, not recruitingPER-063-00
Updated: 2023-09-04
MULTICENTRIC PHASE III STUDY DESIGNED TO EVALUATE ATRAGEN (LIPOSOMAL TRETINOIN ) IN THE TREATMENT OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN FIRST OR SUBSEQUENT RECIDIVES
Active, not recruitingPER-061-00
Updated: 2023-09-04
PHASE II MULTICENTER STUDY OF ATRAGEN (LIPOSOMAL-TRETINOIN) IN PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTXG LEUKEMIA (APL)
Active, not recruitingPER-062-00
Updated: 2023-09-04